1/5/2023
RedChip Logo

RedChip Companies

Weekly Newsletter
 

Unicycive Achieves Primary Endpoint in Pivotal Bioequivalence Study of Renazorb

Unicycive (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, announced that the primary endpoint was met in the Company’s pivotal bioequivalence (BE) study comparing Renazorb to Fosrenol. Based on the topline results, pharmacodynamic (PD) BE of Renazorb to Fosrenol was established and met the regulatory criteria for PD BE in the healthy volunteer BE study.

For more information, visit www.unicycive.com

 
See More Info
 
 
 

Can-Fite Updates: Namodenoson Increases Survival for the Most Severe Patients with Advanced Liver Cancer

Can-Fite BioPharma (NYSE American: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, provided an update on its clinical program for Namodenoson in the treatment of hepatocellular carcinoma (HCC), the most common form of liver cancer. A pivotal Phase III registration study is open for enrollment of the most advanced liver cancer patients. At two upcoming bio-partnering conferences, Can-Fite will be presenting the latest data comparing the response of liver cancer patients to those with HCC Child-Pugh B (CPB), the most advanced liver cancer. The Company will also share the latest findings on a CPB liver cancer patient who remains cancer-free 6 years after she began treatment with Namodenoson.

 
Learn More
   

Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products

Sharps Technology (Nasdaq: STSS), an innovative medical device and drug delivery company offering patented, best-in-class syringe products, has commenced manufacturing of their much-needed ultra-low waste smart safety syringe products through their European operation in Hungary. The plant has been producing products and began shipments to support the distribution and sales agreement with Nephron Pharmaceuticals at the end of 2022, and will commence shipments for customer agreements in Europe in early 2023. The production of these specialty syringe products will ramp up over the next several months to increase supply.

 
Learn More
 

Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023

Nutriband (Nasdaq: NTRB), has begun production of its AI Tape brand with an expected launch of the product line in Q1 2023. AI Tape is designed to share many of the benefits of traditional Kinesiology Tape with added soothing and therapeutic ingredients held in suspension with a proprietary adhesive mix.

 
Learn More
 

Greenwich LifeSciences Provides Year End Update

Greenwich Life Sciences (Nasdaq: GLSI), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, provided a year-end update on its Phase 3 clinical trial, Flamingo-01, evaluating the safety and efficacy of GLSI-100 (GP2 + GM-CSF) in HER2/neu positive breast cancer patients who had residual disease or high-risk pathologic complete response at surgery and who have completed both neoadjuvant and postoperative adjuvant trastuzumab based treatment.

 
Learn More
 

 
 

Upcoming Events

5

January

2023

NASDAQ: NTRB - Nutriband
4:15pm Eastern
Nutriband is a transdermal focused pharmaceutical company based in the United States with a goal to improve the safety, comfort and efficacy of existing drugs using transdermal technologies, benefitting patients, physicians, and payers.
 
Sign Up
 

8

January

2023

NYSE American: GNS - Genius Group Limited
8:00am Eastern
Genius Group is a global Edtech and education company with over 2.7 million students in 200 countries. We are developing a future focused, entrepreneur education system that spans from early learning, primary and secondary school, through to university, adult education and corporate training.
 
Sign Up
 

10

January

2023

NASDAQ: STSS - Sharps Technology
11:00am Eastern
Sharps Technology is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation.
 
Sign Up
 

10

January

2023

NASDAQ: SPI - SPI Energy
4:15pm Eastern
SPI Energy Co., Ltd. (SPI) is a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors.
 
Sign Up
 

12

January

2023

NASDAQ: DGLY - Digital Ally
11:00am Eastern
Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production.
 
Sign Up
 

17

January

2023

NASDAQ: RCRT - Recruiter.com
4:15pm Eastern
Recruiter.com is an on-demand recruiting platform providing flexible talent acquisition solutions that scale from startups to the Fortune 100. With an on-tap network of thousands of recruiting professionals, advanced artificial intelligence sourcing software, and recruitment marketing automation, Recruiter.com helps businesses solve today's complex hiring challenges.
 
Sign Up
 

18

January

2023

NASDAQ: RVSN - Rail Vision
11:00am Eastern
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electrooptic sensors, artificial intelligence and deep learning, Rail Vision systems detect objects on and along the tracks from a distance of up to two kilometers – in real time – as well as in all weather and light conditions.
 
Sign Up
 

18

January

2023

NASDAQ: IINN - Inspira Technologies
4:15pm Eastern
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure.
 
Sign Up
 

19

January

2023

NASDAQ: APM - Aptorum Group
4:15pm Eastern
Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to developing and commercializing therapeutic assets to treat diseases with unmet medical needs.
 
Sign Up
 

24

January

2023

NASDAQ: ARDS - Aridis Pharmaceuticals
11:00am Eastern
Aridis Pharmaceuticals is a late-stage clinical development company, leading the creation of transformative, first-in-class anti-infectives for life-threatening viral and bacterial respiratory infections.
 
Sign Up
 

24

January

2023

NASDAQ: SIDU - Sidus Space
4:15pm Eastern
Sidus Space Inc is a Space-as-a-Service company focused on commercial satellite design, manufacture, launch, and data collection with a vision to enable space flight heritage status for new technologies and deliver data and predictive analytics to both domestic and global customers.
 
Sign Up
 

25

January

2023

NASDAQ: SVFD - Save Foods
4:15pm Eastern
Save Foods Inc and its Israeli subsidiary Save Foods Ltd are innovative, dynamic companies dedicated to delivering integrated eco-friendly solutions for improved safety, freshness and quality, every step of the way from field to fork.
 
Sign Up
 

31

January

2023

NASDAQ: MDGS - Medigus Ltd.
11:00am Eastern
An Israeli technology company, Medigus is focused on building innovative growth partnerships, primarily in advanced medical solutions, digital commerce, and electric vehicle (EV) markets.
 
Sign Up
 
 
 

Archive Events

15

December

2022

NASDAQ: UNCY - Unicycive Therapeutics Inc.
Meeting Duration 30 minutes
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases.
 
Watch Replay
 

15

December

2022

NASDAQ: ASPI - ASP Isotopes
Meeting Duration 30 minutes
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries.
 
Watch Replay
 

14

December

2022

NASDAQ: SYTA - Siyata Mobile
Meeting Duration 34 minutes
Siyata Mobile (Siyata or the Company) is a leading developer and distributor of technologically advanced rugged smartphones, in-vehicle mounted IoT cellular communications devices, and cellular signal boosters for global first responders and enterprise customers based on Push-to-Talk Over Cellular (PoC) technology.
 
Watch Replay
 

14

December

2022

NYSE American: CANF - Can-Fite BioPharma Ltd.
Meeting Duration 27 minutes
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Psoriasis, and liver diseases including advanced liver cancer and NASH. Can-Fite’s drugs have an excellent safety profile with experience in over 1,000 patients.
 
Watch Replay
 

12

December

2022

NASDAQ : AMAO - Royalty Management Corporation
Meeting Duration 35 minutes
Royalty Management Corporation is a royalty company building shareholder value to benefit both our shareholders and communities by acquiring and developing high value assets in a sustainable market environment.
 
Watch Replay
 
 
 

Lesson of the Week

Getting a good price is often the critical factor in a winning investment.

 
Learn More
 
 
 
All Videos
Full Episodes
 

RedChip TV

This Week on RedChip TV: Two Small Cap Stocks Poised to Revolutionize Their Industries

Can-Fite: Addressing Autoimmune-Inflammatory and Cancer Diseases

Sidus Space: Providing Mission-Critical Manufacturing for Defense and Space Industries

QYOU Media: Next-Generation Media Company Building Significant Momentum in India

Dr. Jeff Patrick Explains Why Aversa™ Can Be A Game Changer For Drug Delivery Safety

Greenwich LifeSciences: Developing GP2 to Prevent Breast Cancer Recurrences

BioVie: Positive Data from Phase 2 Alzheimer’s and Parkinson’s Trials

Inspira: Game-Changing Solutions for Improved Patient Outcomes

Genetic Technologies: Accelerating the World’s Transition to Genomic-Integrated Healthcare

 
 

MidSouth Week in Review

The S&P was down 0.2% for the week and the markets will be closed on Monday.

 
Learn More
 
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
© 2022 RedChip , All rights reserved